Literature DB >> 19595938

The Frontal Systems Behavior Scale discriminates frontotemporal dementia from Alzheimer's disease.

Paul Malloy1, Geoffrey Tremont, Janet Grace, Laura Frakey.   

Abstract

Frontotemporal dementia (FTD) is characterized by pronounced changes in affect, self-regulation, and social conduct. These behaviors can predate significant cognitive changes and can be the most disabling aspect of FTD, yet there are few scales designed to assess such changes. The Frontal Systems Behavior Scale (FrSBe) is a 46-item behavior rating scale that is intended to measure behavior associated with damage to the frontal systems of the brain, with subscales measuring Apathy, Disinhibition, and Executive Dysfunction. Thirty-four FTD patients and 34 matched patients with dementia of the Alzheimer's type (DAT) were compared on the FrSBe in the present study. Both groups displayed increases in apathy and dysexecutive behaviors after the onset of dementia, but the FTD group exhibited significantly greater change in disinhibition. A discriminant analysis with just two scores from the FrSBe and a memory test correctly classified 81% of the patients into diagnostic group.

Entities:  

Year:  2007        PMID: 19595938     DOI: 10.1016/j.jalz.2007.04.374

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  19 in total

1.  Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response.

Authors:  Theresa M Winhusen; Eugene C Somoza; Daniel F Lewis; Frankie B Kropp; Viviana Elizabeth Horigian; Bryon Adinoff
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

Review 2.  Clinical assessment of social cognitive function in neurological disorders.

Authors:  Julie D Henry; William von Hippel; Pascal Molenberghs; Teresa Lee; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2015-12-16       Impact factor: 42.937

3.  Caregiver burden in frontotemporal degeneration and corticobasal syndrome.

Authors:  Nicole Armstrong; Nicole Schupf; Jordan Grafman; Edward D Huey
Journal:  Dement Geriatr Cogn Disord       Date:  2013-09-10       Impact factor: 2.959

4.  Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction.

Authors:  Theresa Winhusen; Jessica Walker; Gregory Brigham; Daniel Lewis; Eugene Somoza; Jeff Theobald; Veronika Somoza
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-28       Impact factor: 3.829

5.  Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimer's Disease Biomarker Status.

Authors:  Madison Niermeyer; Chad Gaudet; Paul Malloy; Irene Piryatinsky; Stephen Salloway; Petra Klinge; Athene Lee
Journal:  J Int Neuropsychol Soc       Date:  2020-05-20       Impact factor: 2.892

6.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

7.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

8.  Sex differences in disinhibition and its relationship to physical abuse in a sample of stimulant-dependent patients.

Authors:  Theresa Winhusen; Daniel Lewis
Journal:  Drug Alcohol Depend       Date:  2012-10-11       Impact factor: 4.492

Review 9.  The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Authors:  Adam L Boxer; Michael Gold; Edward Huey; William T Hu; Howard Rosen; Joel Kramer; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; George Jackson; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven S Khachaturian; Margaret Sutherland; Susan Abushakra; Joseph Lewcock; Robert Farese; Robert O Kenet; Frank Laferla; Steve Perrin; Steve Whitaker; Lawrence Honig; Marsel M Mesulam; Brad Boeve; Murray Grossman; Bruce L Miller; Jeffrey L Cummings
Journal:  Alzheimers Dement       Date:  2012-10-10       Impact factor: 21.566

10.  Ecological validity and neuroanatomical correlates of the NIH EXAMINER executive composite score.

Authors:  Katherine L Possin; Amanda K LaMarre; Kristie A Wood; Dan M Mungas; Joel H Kramer
Journal:  J Int Neuropsychol Soc       Date:  2013-06-14       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.